« Previous article
Cherwell Offers Proc...

ATCC Vector-borne Research Materials – New!


ATCCBillions of people worldwide are at risk from microorganisms transmitted by mosquitoes, ticks, fleas, and other vectors. Due to the complexity of vector-borne pathogen transmission, and the unpredictable nature of insect vectors, vector-borne illnesses are among the most difficult infectious diseases to predict, prevent, and control.

To help support the development of molecular-based assays for pathogen detection or quantification, ATCC is pleased to announce the release of genomic DNA isolated from Babesia microti, and synthetically-derived RNA representing Dengue virus types I-IV.

ATCC® No.ProductFormatQuantity
30221DGenomic Babesia microti DNAFrozen≥ 5 x 103 copies/µL
VR-3228SDSynthetic Dengue virus type 1 RNAFrozen1x 105 – 1 x 106 copies/ µL
VR-3229SDSynthetic Dengue virus type 2 RNAFrozen1x 105 – 1 x 106 copies/ µL
VR-3230SDSynthetic Dengue virus type 3 RNAFrozen1x 105 – 1 x 106 copies/ µL
VR-3231SDSynthetic Dengue virus type 4 RNAFrozen1x 105 – 1 x 106 copies/ µL

 

These ATCC® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation, and lot-to-lot performance of molecular-based assays. Moreover, their quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR).

For more information on vector-borne illnesses, or to search for strains and nucleic acids to support your research, please visit us online at www.atcc.org/vectorborne.


      

Tags:

Date Published: 25th August 2014

Source article link: ATCC


View full company details


Related news